Klas receive prestigious Women TechEU award

We are delighted to announce that Klas Therapeutics and our CEO, Prof. Bridgeen Callan, are among the 40 winners of the Women TechEU award. The program received over 800 applications from a range of deep tech female lead companies from across Europe. This EU funded...

Klas is a regional finalist for Seedcorn

KlasTx is delighted to confirm that we have been selected as regional finalists in the InterTradeIreland Seedcorn competition 2024. The Seedcorn Investor Readiness Competition is designed for start-ups and early-stage businesses and is seen as the perfect chance to...

Innovate UK ICURe exploit success for Klas

Through the mentorship and guidance of the ICURe programme, KlasTx  was awarded a circa £300,000 grant from Innovate UK. This grant allowed KlasTx to focus on preclinical developments which will aid in commercialisation pathway of our proprietary technology. This...

Klas partners with Medicines Discovery Catapult (MDC)

Klas partners with Medicines Discovery Catapult (MDC) in a successful Innovate UK Biomedical Catalyst grant. Following a successful grant application with Innovate UK, generating impressive pilot data, Klas Therapeutics have partnered with MDC in a successful grant...